Abstract
UCSF researchers have used a zebrafish screen to identify an adenosine receptor agonist that improved both β cell regeneration and glucose control in diabetic mice. The discovery could open up a new indication for a class of compounds that until now have been developed mainly for inflammatory and cardiovascular disorders.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
